Heart Risks Also Seen In Naproxen, Health Agency Says

	Tweet

The National Institutes of Health is halting a study testing whether Celebrex—or naproxen—would reduce the risk of Alzheimer’s disease.

Both pain relievers are commonly used to treat arthritis.

NIH officials said the study was stopped after three years when it was noticed that patients taking naproxen had a 50 percent greater incidence of heart attack or stroke than patients taking a placebo.

Another factor was the announcement on Monday that advertising for Celebrex was being halted after a study found that high doses of the drug was associated with an increase in heart attack risk.

The Food and Drug Administration says patients who routinely take naproxen should follow the drug directions carefully and consult a doctor if their pain continues.

Naproxen, sold under the brand name Aleve, is the third medicine used for arthritis pain that has been linked to heart problems. Naproxen has been approved for sale, first as a prescription and then as an over-the-counter drug, since 1976.

Manufacturers pulled arthritis drug Vioxx off the shelves on Sept. 30 over concerns about a possible connection to fatal heart problems.

And last week, drug maker Pfizer said the arthritis painkiller Celebrex could increase the risk of a heart attack or a stroke if taken in very large doses. But it says it won’t take Celebrex off the market, although on Monday said it would halt advertising the drug. Federal scientists have halted a study testing Celebrex for cancer prevention.

-----------------------------------
CELEBREX © is a recent break through in the treatment of osteoarthritis and rheumatioid arthritis.Celebrex ® is being hailed by many as a miracle drug. Celebrex enables people to live more active lives, not limited by arthritis pain.

Order CELEBREX online !
-----------------------------------

RELATED STORIES:
ACE inhibitors helpful in heart and kidney disease   Glaxo Seeks Entry Into U.S. Flu Vaccine Mkt   FDA approves automated hepatitis C virus assay on ADVIA Centaur Immunoassay system   Pharmacokinetics of tramadol in children   Johnson & Johnson Receives Subpoena   Newer Antidepressants Work 2 Ways   Hib vaccines act differently in old and young   Short-Term Celebrex Safe Against Cirrhosis   Study supports controversial blood-thinning drug   Progress made toward gonorrhea vaccine   Scientists in Kenya to push African vaccine research   Painkiller Vioxx Often Taken at Too High Dose

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]